Global Therapeutic Devices for Dry Eye Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Therapeutic Devices for Dry Eye Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

  • Healthcare
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Therapeutic Devices For Dry Eye Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Therapeutic Devices For Dry Eye Market size in 2024 - 2.00 and 2032 - 3.90, highlighting the projected market growth. USD 2.00 Billion USD 3.90 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 2.00 Billion
Diagram Market Size (Forecast Year)
USD 3.90 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Therapeutic Devices for Dry Eye Market Segmentation, By Device Type (Punctal Plugs, LipiFlow, Intense Pulsed Light Therapy Devices, and Others), Technology (Thermal Pulsation, Meibomian Gland Expression, and Others), Application (Chronic Dry Eye, Acute Dry Eye, and Others), End User (Hospitals, Ophthalmology Clinics, and Others), Distribution Channel (Direct Sales and Retail Sales) – Industry Trends and Forecast to 2032

Therapeutic Devices for Dry Eye Market

Therapeutic Devices for Dry Eye Market Analysis

The therapeutic devices for dry eye market is experiencing significant growth due to rising awareness of the condition and the demand for effective treatment solutions. A key development in this market is the innovation of advanced treatment technologies, such as thermal pulsation and intense pulsed light therapy, which have significantly improved treatment outcomes. These technologies help in restoring the natural lubrication of the eyes by targeting underlying causes such as meibomian gland dysfunction. LipiFlow, a leading thermal pulsation device, is among the most widely adopted solutions, offering a non-invasive, effective therapy for dry eye patients.

In addition, advancements in personalized treatment approaches are gaining traction. Devices such as punctal plugs and thermal pulsation systems are becoming more tailored to the individual needs of patients, enhancing their overall effectiveness. The increasing prevalence of dry eye, coupled with technological progress in the devices used for treatment, is driving market growth. Furthermore, growing healthcare infrastructure and the rising geriatric population, more prone to dry eye disease, are contributing to this market’s expansion.

Therapeutic Devices for Dry Eye Market Size

The global Therapeutic Devices for Dry Eye Market size was valued at USD 2.00 Billion in 2024 and is projected to reach USD 3.90 Billion by 2032, with a CAGR of 8.30% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Therapeutic Devices for Dry Eye Market Trends

"Technological Innovations Driving Treatment Effectiveness"

One major trend in the therapeutic devices for dry eye market is the continual development of more advanced and efficient technologies. Devices such as LipiFlow and intense pulsed light therapy have revolutionized the treatment of dry eye, allowing for better management of the condition with fewer side effects and reduced patient discomfort. These technologies are primarily designed to address meibomian gland dysfunction, one of the leading causes of dry eye disease. Furthermore, the integration of AI in these devices is enhancing their efficacy by offering more precise treatment plans based on individual patient data. As a result, patients benefit from highly customized therapies, which significantly boosts the therapeutic success rates, expanding the market for such devices.

Report Scope and Therapeutic Devices for Dry Eye Market Segmentation         

Attributes

Therapeutic Devices for Dry Eye Key Market Insights

Segments Covered

  • By Device Type: Punctal Plugs, LipiFlow, Intense Pulsed Light Therapy Devices, and Others 
  • By Technology: Thermal Pulsation, Meibomian Gland Expression, and Others 
  • By Application: Chronic Dry Eye, Acute Dry Eye, and Others 
  • By End User: Hospitals, Ophthalmology Clinics, and Others 
  • By Distribution Channel: Direct Sales and Retail Sales

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

TearScience, Inc. (U.S.), Johnson & Johnson Vision (U.S.), Allergan, Inc. (Ireland), Bausch + Lomb (U.S.), Novartis International AG (Switzerland), Regeneron Pharmaceuticals, Inc. (U.S.), AbbVie, Inc. (U.S.), Hoya Corporation (Japan), Alcon Inc. (Switzerland), Eyenovia, Inc. (U.S.), Oasis Medical, Inc. (U.S.), TheraTears (U.S.), Lumenis Ltd. (Israel), Zywie, Inc. (U.S.), EyeGate Pharmaceuticals, Inc. (U.S.), Kala Pharmaceuticals, Inc. (U.S.), Shire Pharmaceuticals (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Blink Therapeutics (U.K.), Mojo Vision, Inc. (U.S.)

Market Opportunities

  • Growing Prevalence of Dry Eye Disease
  • Advancements in Non-Surgical Treatment Options

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Therapeutic Devices for Dry Eye Market Definition

The global therapeutic devices for dry eye market focuses on the development, manufacturing, and commercialization of medical devices designed to alleviate the symptoms of dry eye disease (DED). Dry eye occurs when the eyes do not produce enough tears or the tears evaporate too quickly, leading to irritation, discomfort, and potential damage to the ocular surface. Therapeutic devices include technologies such as punctal plugs, intense pulsed light (IPL) therapy, thermal pulsation systems, and lipiflow systems that restore tear production, reduce inflammation, and improve ocular health. The market is driven by factors such as increasing awareness of dry eye disease, rising prevalence of risk factors (e.g., aging population, digital screen use), and advancements in medical device technology. The demand for these therapeutic devices continues to grow as more individuals seek effective treatment options for managing dry eye symptoms.

Therapeutic Devices for Dry Eye Market Dynamics

Drivers

  • Rising Prevalence of Dry Eye Disease (DED)

The growing incidence of dry eye disease is a major driver for the global therapeutic devices market. Factors such as aging populations, increased screen time, and environmental factors contribute to the rising cases of DED. For instance, in countries with high digital device usage, such as the U.S. and South Korea, screen-related eye strain is becoming more prevalent, driving demand for dry eye therapies. Therapeutic devices such as LipiFlow and BlephEx are seeing increased adoption to manage and alleviate symptoms of DED.

  • Technological Advancements in Treatment Devices

Innovation in medical devices is accelerating the market growth. Devices that offer non-invasive and effective treatment options are gaining traction among patients and healthcare providers. For instance, devices such as intense pulsed light (IPL) therapy systems, which improve meibomian gland function, and eye-drop delivery systems are evolving to provide better outcomes with less discomfort. These advancements make treatment more accessible and appealing, spurring market expansion.

Opportunities

  • Expansion in Emerging Markets

There is significant growth potential for dry eye therapeutic devices in emerging markets, such as Asia-Pacific, Latin America, and parts of Africa. Increasing healthcare access, improving living standards, and rising awareness about eye health are driving the demand for effective treatments. In countries such as India and Brazil, there is an opportunity to introduce affordable and efficient dry eye therapies, thereby expanding market reach. This growth can be supported by local partnerships and region-specific product adaptations.

  • Integration of AI and Smart Technologies

The incorporation of artificial intelligence (AI) and smart technologies into dry eye treatment devices offers substantial opportunities. Devices that use AI for personalized treatment plans, such as tailored moisture level tracking or real-time eye health monitoring, can improve patient outcomes. For instance, wearable devices or smart contact lenses that assess and adjust treatment based on real-time data could revolutionize how dry eye disease is managed, offering a more proactive and effective approach.

Restraints/Challenges

  • High Treatment Costs

A major restraint in the global therapeutic devices market for dry eye disease is the high cost associated with advanced treatment options. Devices such as LipiFlow, which provides thermal pulsation treatment, or intense pulsed light therapy systems, can be expensive, limiting access for many patients, especially in lower-income regions or among individuals without sufficient insurance coverage. These high upfront costs can deter widespread adoption, particularly in emerging markets where affordable alternatives are more sought after. Moreover, limited insurance reimbursement for such therapies in some countries further exacerbates the challenge, making it difficult for patients to afford long-term treatment.

  • Lack of Awareness and Diagnosis

Another significant challenge is the lack of awareness and proper diagnosis of dry eye disease, which impedes the demand for therapeutic devices. Many people with early symptoms of dry eye disease may not recognize the condition or attribute it to other causes, leading to delayed treatment. Additionally, dry eye disease can often be misdiagnosed due to its overlap with other eye conditions. In regions where awareness is low or healthcare infrastructure is underdeveloped, many individuals may not seek or receive timely treatment. This results in a smaller target patient population, limiting the growth potential of the market for dry eye therapeutic devices.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Therapeutic Devices for Dry Eye Market Scope

The market is segmented on the basis of device type, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

  • Punctal Plugs
  • LipiFlow
  • Intense Pulsed Light Therapy Devices
  • Others

Technology

  • Thermal Pulsation
  • Meibomian Gland Expression
  • Others

Application

  • Chronic Dry Eye
  • Acute Dry Eye
  • Others

End User

  • Hospitals
  • Ophthalmology Clinics
  • Others

Distribution Channel

  • Direct Sales
  • Retail Sales

Therapeutic Devices for Dry Eye Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, device type, technology, application, end user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, U.A.E, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America is expected to dominate the Therapeutic Devices for Dry Eye Market due to the significant increase in research and development investments, along with the growing number of government initiatives to enhance healthcare. The region benefits from advanced healthcare infrastructure, which drives demand for sophisticated diagnostic tools such as clinical microscopes. In addition, the presence of leading manufacturers and continuous technological advancements further support North America's leadership in the market. This growth is further fueled by the rising healthcare awareness and medical needs.

Asia-Pacific is expected to exhibit the highest growth rate in the Therapeutic Devices for Dry Eye Market during the forecast period due to increasing government expenditure on the healthcare sector. The region's rising technological advancements and government initiatives to improve healthcare infrastructure are key drivers of market growth. In addition, growing investments in medical research and healthcare facilities in countries such as China, India, and Japan are further boosting the demand for clinical microscopes in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Therapeutic Devices for Dry Eye Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Therapeutic Devices for Dry Eye Market Leaders Operating in the Market Are:

  • TearScience, Inc. (U.S.)
  • Johnson & Johnson Vision (U.S.)
  • Allergan, Inc. (Ireland)
  • Bausch + Lomb (U.S.)
  • Novartis International AG (Switzerland)
  • Regeneron Pharmaceuticals, Inc. (U.S.)
  • AbbVie, Inc. (U.S.)
  • Hoya Corporation (Japan)
  • Alcon Inc. (Switzerland)
  • Eyenovia, Inc. (U.S.)
  • Oasis Medical, Inc. (U.S.)
  • TheraTears (U.S.)
  • Lumenis Ltd. (Israel)
  • Zywie, Inc. (U.S.)
  • EyeGate Pharmaceuticals, Inc. (U.S.)
  • Kala Pharmaceuticals, Inc. (U.S.)
  • Shire Pharmaceuticals (U.S.)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Blink Therapeutics (U.K.)
  • Mojo Vision, Inc. (U.S.)

Latest Developments in Therapeutic Devices for Dry Eye Market

  • In June 2024, Lacrifill, a canalicular gel device, was introduced in the US as an effective, safe, and well-tolerated treatment for dry eye. The device occludes the canalicular system, offering a novel alternative to punctal plugs with minimal side effects and a six-month duration.
  • In December 2023, Nordic Pharma, through its subsidiary Amring Pharmaceuticals, has acquired Visant Medical and plans to launch the Lacrifill canalicular occlusive device for dry eye disease (DED) in the United States. The FDA-cleared device temporarily blocks tear drainage by occluding the canalicular system. Nordic aims to introduce Lacrifill to U.S. ophthalmologists and optometrists treating over 16 million DED patients, with a goal to make it the standard for preoperative care. Following the U.S. launch in 2024, Nordic plans to seek global regulatory approval.
  • In June 2023, Novartis has agreed to divest its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including Xiidra for dry eye disease and SAF312 (libvatrep) for chronic ocular surface pain. This aligns with Novartis' strategy to focus on prioritized therapeutic areas. The deal also includes milestone payments up to USD 750 million and a transitional supply agreement for Xiidra. Novartis will continue its research on retinal diseases through platforms such as gene therapy and optogenetics.
  • In December 2022, China Pharma Holdings has acquired a patented therapeutic device for dry eye disease (DED). With DED affecting 25-30% of the population, and 75% of those over 65 in China, the acquisition targets a growing market. The device, designed for treating DED, visual fatigue, and aiding recovery post-eye surgery, fills a gap in the market for medical therapeutic devices. China Pharma aims to launch the device next year, expecting it to enhance treatment experiences for patients and drive company sales growth.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Therapeutic Devices for Dry Eye Market Segmentation, By Device Type (Punctal Plugs, LipiFlow, Intense Pulsed Light Therapy Devices, and Others), Technology (Thermal Pulsation, Meibomian Gland Expression, and Others), Application (Chronic Dry Eye, Acute Dry Eye, and Others), End User (Hospitals, Ophthalmology Clinics, and Others), Distribution Channel (Direct Sales and Retail Sales) – Industry Trends and Forecast to 2032 .
The Global Therapeutic Devices for Dry Eye Market size was valued at USD 2.00 USD Billion in 2024.
The Global Therapeutic Devices for Dry Eye Market is projected to grow at a CAGR of 8.3% during the forecast period of 2025 to 2032.
The market report covers data from U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Testimonial